COMMUNIQUÉS West-GlobeNewswire

-
Solésence Reports Second Quarter 2025 Financial Results
31/07/2025 -
Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
31/07/2025 -
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
31/07/2025 -
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
31/07/2025 -
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed
31/07/2025 -
Orchestra BioMed Announces Proposed Public Offering
31/07/2025 -
Stryker reports second quarter 2025 operating results
31/07/2025 -
Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025
31/07/2025 -
Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
31/07/2025 -
Synergy CHC Corp. Announces Second Quarter 2025 Earnings and Conference Call Information
31/07/2025 -
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
31/07/2025 -
LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia
31/07/2025 -
CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025
31/07/2025 -
Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
31/07/2025 -
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025
31/07/2025 -
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results
31/07/2025 -
Safety Shot Appoints Markita Russell as Chief Financial Officer
31/07/2025 -
4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update
31/07/2025 -
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025
31/07/2025
Pages